Loading...

Major Indexes

Financial Summary


Ablynx NV

Ablynx NV (ABLX)

$52.78
0 (0.00%)
-
-
Market Info
Financial Info
Financial Modelling
Symbol ABLX
Price 52.78$
Beta 8.24
Volume Avrg. 0.13M
Market Cap 3.27B
Shares () -
Last Div 0
Dividend Yield -
DCF Unlevered -
DCF Levered -
ROE NaN%
ROA NaN%
Operating Margin NaN%
Debt / Equity NaN%
P/E -
P/B -

Income Statement

Quarter data
Download ABLX income statement Download ABLX income statement Download ABLX income statement
Year
Earnings Per Share Diluted
Net Profit Margin
Weighted Average Shares Outstanding
Revenue
Weighted Average Shares Outstanding (Diluted)
Gross Profit
Dividend per Share
Operating Income
Gross Margin
Income Tax Expense
EBIT Margin
Net Income
Cost of Revenue
Earnings Before Tax Margin
EBIT
EBITDA
Profit Margin
Operating Expenses
Earnings Per Share Basic
Earnings before Tax
Interest Expense

Balance Sheet Statement

Quarter data
Download ABLX balance shet statement Download ABLX balance sheet statement Download ABLX balance sheet statement
Year
Short-term debt
Other Assets
Total current liabilities
Cash and cash equivalents
Long-term debt
Cash and short-term investments
Total debt
Inventories
Deferred revenue
Goodwill and Intangible Assets
Total non-current liabilities
Total non-current assets
Total liabilities
Total assets
Other comprehensive income
Short-term investments
Property, Plant & Equipment Net
Net Debt
Investments
Total shareholders equity
Retained earnings (deficit)
Long-term investments
Receivables
Payables
Total current assets

Cash Flow Statement

Quarter data
Download ABLX cash flow statement Download ABLX cash flow statement Download ABLX cash flow statement
Year
Investing Cash Flow
Free Cash Flow
Depreciation & Amortization
Net cash flow / Change in cash
Effect of forex changes on cash
Financing Cash Flow
Dividend payments
Stock-based compensation
Investment purchases
Acquisitions and disposals
Capital Expenditure
Operating Cash Flow

Retained Earning Schedule

Year
Retained Earnings (Previous Year)
Net Income
Stock Dividends
Dividend Paid
Retained Earnings

PPE Schedule

Year
Gross PPE
Annual Depreciation
Capital Expenditure
Net PPE

Intangible and Goodwill Schedule

Year
Intangible and Goodwill (Previous Year)
New Purchases
Intangible and Goodwill

About


None
Healthcare
Biotechnology
Nasdaq Global Select

Ablynx NV is a clinical-stage biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.